BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 33130741)

  • 21. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
    Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastasizing ectopic thymoma arising in the right thoracic cavity and mimicking diffuse pleural mesothelioma--an autopsy study of a case with review of literature.
    Honma K; Shimada K
    Wien Klin Wochenschr; 1986 Jan; 98(1):14-20. PubMed ID: 3953100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
    Thomas A; Rajan A; Berman A; Tomita Y; Brzezniak C; Lee MJ; Lee S; Ling A; Spittler AJ; Carter CA; Guha U; Wang Y; Szabo E; Meltzer P; Steinberg SM; Trepel JB; Loehrer PJ; Giaccone G
    Lancet Oncol; 2015 Feb; 16(2):177-86. PubMed ID: 25592632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
    Hirai F; Seto T; Yamanaka T; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
    Jpn J Clin Oncol; 2013 Oct; 43(10):1018-22. PubMed ID: 23917962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).
    Rabasseda X
    Drugs Today (Barc); 2015 Sep; 51(9):559-67. PubMed ID: 26488035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread.
    Chen KC; Hsieh YS; Tseng YF; Shieh MJ; Chen JS; Lai HS; Lee JM
    PLoS One; 2015; 10(7):e0133230. PubMed ID: 26193470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Outpatient chemotherapy for advanced lung cancer].
    Okazaki M; Katakami N; Nishio C; Fujita S; Kaneshiro E; Nishimura T; Ikeda A; Hasegawa T; Umeda B
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1391-5. PubMed ID: 11681246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.
    Xia H; Karasawa K; Hanyu N; Chang TC; Okamoto M; Kiguchi Y; Kawakami M; Itazawa T
    Int J Hyperthermia; 2006 Nov; 22(7):613-21. PubMed ID: 17079218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodality therapy for thymoma patients with pleural dissemination.
    Nakamura S; Kawaguchi K; Fukui T; Hakiri S; Ozeki N; Mori S; Goto M; Hashimoto K; Ito T; Yokoi K
    Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):524-529. PubMed ID: 30725276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of radiation therapy in thoracic tumors.
    Kong FM; Zhao L; Hayman JA
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):363-400. PubMed ID: 16730299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients.
    Maruyama R; Suemitsu R; Okamoto T; Kojo M; Aoki Y; Wataya H; Eguchi T; Nishiyama K; Seto T; Ichinose Y
    Oncology; 2006; 70(5):325-9. PubMed ID: 17164588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The usefulness of induction chemotherapy in cases with tumors showing border-line pathological aspects between thymoma and thymic carcinoma].
    Nonami Y; Moriki T; Yamamoto A; Yamashiro T; Sasaguri S; Nakata H; Kobayashi M
    Kyobu Geka; 2002 Oct; 55(11):953-8. PubMed ID: 12391692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperthermic intrathoracic chemotherapy in thoracic surgery].
    Hofmann HS; Ried M
    Chirurg; 2019 Aug; 90(8):681-694. PubMed ID: 31218434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma.
    Kawasaki H; Taira N; Ichi T; Yohena T; Kawabata T; Ishikawa K
    Eur J Surg Oncol; 2014 Sep; 40(9):1151-5. PubMed ID: 24703656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical thymoma: a report of seven patients.
    Baran JL; Magro CM; King MA; Williams TE; Ross P
    Ann Thorac Surg; 2004 Aug; 78(2):411-6. PubMed ID: 15276487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
    Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
    Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total remission of thymus carcinoma after treatment with intravenous immunoglobulin.
    Murie-Fernández M; Gurpide A; de la Cruz S; de Castro P
    Clin Transl Oncol; 2006 Sep; 8(9):697-9. PubMed ID: 17005475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers].
    Duruisseaux M; Rouquette I; Adam J; Cortot A; Cazes A; Gibault L; Damotte D; Lantuejoul S
    Ann Pathol; 2017 Feb; 37(1):61-78. PubMed ID: 28162296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
    Ikeda S; Kato T; Ogura T; Sekine A; Oda T; Masuda N; Igawa S; Katono K; Otani S; Yamada K; Saito H; Kondo T; Hosomi Y; Nakahara Y; Nishikawa M; Utumi K; Misumi Y; Yamanaka T; Sakamaki K; Okamoto H
    BMC Cancer; 2018 Mar; 18(1):241. PubMed ID: 29499653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.
    Loehrer PJ; Wang W; Johnson DH; Aisner SC; Ettinger DS;
    J Clin Oncol; 2004 Jan; 22(2):293-9. PubMed ID: 14722038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.